Quantcast

Latest gene expression Stories

2014-09-29 08:29:58

MARLBOROUGH, Mass., Sept. 29, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 13(th) Annual BIO Investor Forum on Tuesday, October 7, 2014 at 10:00 a.m. PST. Dr. Cauwenbergh will...

2014-09-26 16:23:31

DALLAS, September 26, 2014 /PRNewswire/ -- According to the new market research report "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019", published by MarketsandMarkets, the global Transcriptomics Market is estimated to be worth $1985.5 Million by the end of 2014 and is expected to...

2014-09-19 16:24:35

DUBLIN, September 19, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/j8jfz4/global) has announced the addition of the "Global Transcriptomics Market 2014-2018" [http://www.researchandmarkets.com/research/j8jfz4/global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Transcriptomics studies involve the collection and analysis of transcriptomes of different types of cells or tissues of...

2014-09-18 08:29:06

MARLBOROUGH, Mass., Sept. 18, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the 7(th) Annual BioPharm America(TM) Conference on Wednesday, September 24, 2014 at 11:20 a.m. EDT. Dr....

2014-09-18 08:24:06

ST. LOUIS, Sept. 18, 2014 /PRNewswire/ -- U.S. biotech company Kultevat has strengthened its technology portfolio by signing an exclusive license for technology developed by the Donald Danforth Plant Science Center to control gene expression in plants, including for applications in production of natural rubber in Taraxicum species. http://photos.prnewswire.com/prnvar/20140917/146847 The technology was developed under the direction of Roger Beachy, Ph.D., chief science officer at...

2014-09-17 08:29:00

Patents granted by the United States Patent and Trademark Office and European Patent Office and a notice of allowance from the Japanese Patent Office broaden the breadth of the Company's delivery technology platform MARLBOROUGH, Mass., Sept. 17, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies,...

sea lamprey
2014-09-16 02:30:52

Kim Bland, Ph.D., Stowers Institute for Medical Research Sea lamprey studies show remarkably conserved gene expression patterns in jawless versus jawed vertebrates If you never understood what “ontogeny recapitulates phylogeny” meant in high school, don’t worry: biologists no longer think that an animal’s “ontogeny”, that is, its embryonic development, replays its entire evolutionary history. Instead, the new way to figure out how animals evolved is to compare regulatory...

2014-09-08 08:29:41

BERGEN, Norway, September 8, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the United States Patent and Trademark Office (USPTO) has issued United States Patent 8,735,064 covering a method for creating and identifying functional interference RNA (RNAi) molecules (1). RNAis are recombinant nucleic acid molecules that have the ability to specifically down-regulate an expressed target gene in vivo....

2014-09-03 23:12:42

The webinar, in partnership with Asuragen, will be presented live September 10, 2014 1:00pm Eastern Time (PRWEB) September 03, 2014 LabRoots announces a new educational webinar for the NGS community. The webinar, titled “NGS Lessons in Translational Diagnostics: Mining and Migrating Robust Cancer Biomarkers to Unified DNA and RNA NGS Panels,” will be airing live September 10, 2014 1:00pm Eastern Time. In this webinar, a comprehensive approach for NGS-based biomarker discovery will...

2014-09-03 16:22:19

AUSTIN, Texas, Sept. 3, 2014 /PRNewswire/ -- Western Blot Service CRO, a biology contract research organization based in Austin, Texas, announced today that it is consolidating its years of expert research experience in protein expression into a new service capability, to use a WES automated protein expression system (http://www.westernblotservice.com). Western Blot Service CRO is a division of Altogen Labs (http://www.altogenlabs.com) that will take advantage of the fundamental...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related